BSE Live
Oct 06, 14:25Prev. Close
311.75
Open Price
300.60
Bid Price (Qty.)
306.00 (61)
Offer Price (Qty.)
314.00 (1)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Balance Sheet of Samrat Pharmachem (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | |
Total Share Capital | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | |
Reserves and Surplus | 21.21 | 16.98 | 15.44 | 12.22 | 10.67 | |
Total Reserves and Surplus | 21.21 | 16.98 | 15.44 | 12.22 | 10.67 | |
Total Shareholders Funds | 24.30 | 20.07 | 18.53 | 15.31 | 13.76 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.31 | 0.76 | 1.17 | 1.53 | |
Deferred Tax Liabilities [Net] | 0.14 | 0.32 | 0.31 | 0.30 | 0.42 | |
Other Long Term Liabilities | 0.00 | 0.20 | 0.20 | 0.20 | 0.00 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 0.14 | 0.83 | 1.27 | 1.66 | 1.96 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 9.10 | 5.77 | 8.22 | 5.42 | 3.70 | |
Trade Payables | 23.15 | 12.66 | 10.40 | 7.30 | 16.09 | |
Other Current Liabilities | 0.44 | 0.53 | 1.00 | 5.79 | 0.57 | |
Short Term Provisions | 1.22 | 0.37 | 1.41 | 0.60 | 0.10 | |
Total Current Liabilities | 33.90 | 19.33 | 21.02 | 19.10 | 20.46 | |
Total Capital And Liabilities | 58.35 | 40.23 | 40.83 | 36.08 | 36.17 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 7.18 | 6.84 | 6.96 | 6.97 | 7.22 | |
Intangible Assets | 0.00 | 0.03 | 0.03 | 0.05 | 0.06 | |
Capital Work-In-Progress | 1.08 | 0.00 | 0.00 | 0.20 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 8.27 | 6.86 | 6.99 | 7.21 | 7.28 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.17 | 0.10 | 0.09 | 0.10 | 0.12 | |
Other Non-Current Assets | 0.23 | 0.51 | 0.49 | 0.47 | 0.41 | |
Total Non-Current Assets | 8.67 | 7.47 | 7.56 | 7.79 | 7.81 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | |
Inventories | 18.77 | 7.93 | 6.85 | 7.02 | 5.68 | |
Trade Receivables | 27.81 | 21.05 | 21.89 | 11.84 | 16.10 | |
Cash And Cash Equivalents | 1.17 | 2.25 | 3.98 | 2.44 | 3.50 | |
Short Term Loans And Advances | 0.02 | 0.02 | 0.02 | 0.02 | 0.08 | |
OtherCurrentAssets | 1.90 | 1.51 | 0.53 | 6.97 | 1.01 | |
Total Current Assets | 49.68 | 32.76 | 33.27 | 28.30 | 28.37 | |
Total Assets | 58.35 | 40.23 | 40.83 | 36.08 | 36.17 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.07 | 0.43 | 0.36 | 0.37 | 0.37 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 111.54 | 84.40 | 58.81 | 58.81 | 42.11 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 6.93 | 18.39 | 11.42 | 10.34 | 11.80 | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | 0.00 | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | 2.00 |
10.06.2025
Samrat Pharma Standalone March 2025 Net Sales at Rs 71.20 crore, down 13.88% Y-o-Y
25.11.2024
Samrat Pharma Standalone September 2024 Net Sales at Rs 70.17 crore, down 12% Y-o-Y
17.08.2024
Samrat Pharma Standalone June 2024 Net Sales at Rs 80.82 crore, up 40.61% Y-o-Y
07.06.2024
Samrat Pharma Standalone March 2024 Net Sales at Rs 82.68 crore, up 19.52% Y-o-Y
10.06.2025
Samrat Pharma Standalone March 2025 Net Sales at Rs 71.20 crore, down 13.88% Y-o-Y
25.11.2024
Samrat Pharma Standalone September 2024 Net Sales at Rs 70.17 crore, down 12% Y-o-Y
17.08.2024
Samrat Pharma Standalone June 2024 Net Sales at Rs 80.82 crore, up 40.61% Y-o-Y
07.06.2024
Samrat Pharma Standalone March 2024 Net Sales at Rs 82.68 crore, up 19.52% Y-o-Y